APPROPRIATE USE OF CA125 IN MONITORING OF OVARIAN CANCER- ADVANTAGE OR DISADVANTAGE FOR AN INDIVIDUAL PATIENT

被引：0
|
作者：
Zwirner, M. [1 ]
Korte, K. [1 ]
机构：
[1] Univ Tubingen, Frauenklin, D-72076 Tubingen, Germany
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页码：6856 / 6856
页数：1
相关论文
共 50 条
  • [21] Potential value of CA125 kinetic monitoring in the initial management of advanced epithelial ovarian cancer
    Vignot, Stephane
    Brochet, Christine
    Debord, Camille
    Lauratet, Betty
    Bernard, Maguy
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (05) : 597 - 604
  • [22] Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
    Gupta, Digant
    Lammersfeld, Carolyn A.
    Vashi, Pankaj G.
    Braun, Donald P.
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [23] THE VALUE OF SERUM CA125 FOR MONITORING THE RECURRENCE OF EPITHELIAL OVARIAN CARCINOMA
    Guo, N.
    Zhilan, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 56 - 56
  • [24] Correlates of the preoperative level of CA125 at presentation of ovarian cancer
    Cramer, Daniel W.
    Vitonis, Allison F.
    Welch, William R.
    Terry, Kathryn L.
    Goodman, Annekathryn
    Rueda, Bo R.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (03) : 462 - 468
  • [25] Combined inhibin and CA125 assays in the detection of ovarian cancer
    Robertson, DM
    Cahir, N
    Burger, HG
    Mamers, P
    McCloud, PI
    Pettersson, K
    McGuckin, M
    CLINICAL CHEMISTRY, 1999, 45 (05) : 651 - 658
  • [26] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [27] CA125 response to bevacizumab in recurrent ovarian cancer.
    O'Cearbhaill, R. E.
    Zhou, Q.
    Iasonos, A.
    Diaz, J. P.
    Tew, W. P.
    Hensley, M. L.
    O'Flaherty, C.
    Aghajanian, C.
    Spriggs, D. R.
    Sabbatini, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Andre T Baron
    Nita Maihle
    Nature Clinical Practice Oncology, 2005, 2 : 288 - 289
  • [29] Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
    Digant Gupta
    Carolyn A Lammersfeld
    Pankaj G Vashi
    Donald P Braun
    Journal of Ovarian Research, 3
  • [30] Beyond CA125: the coming of age of ovarian cancer biomarkers
    Sasaroli, Dimitra
    Coukos, George
    Scholler, Nathalie
    BIOMARKERS IN MEDICINE, 2009, 3 (03) : 275 - 288
12345